Some RNF43 mutations cause loss of function, promote β-catenin stabilization, and induce tumorigenesis; RNF43 mutations are frequently observed in gastric, ovarian, pancreatic, endometrial, colon, and liver cancers [13,14]. This evidence concerns the gene RNF43 and liver cancer.